| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.645 | 61.104 | 94.928 | 2.364 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 46.699 | 61.121 | 94.928 | 2.364 | 6.322 | 116 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 45.387 | 64.331 | 100.825 | 8.933 | 9.499 | 3.984 | 2.144 | 1.641 | 35.635 | 25.772 |
| Gross Profit/Loss - EUR | 1.311 | -3.210 | -5.897 | -6.569 | -3.177 | -3.868 | -2.144 | -1.641 | -35.635 | -25.772 |
| Net Profit/Loss - EUR | 1.311 | -3.210 | -5.897 | -6.569 | -3.177 | -3.868 | -2.144 | -1.641 | -35.635 | -25.772 |
| Employees | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Corax-Bioner Biotechnologiai Sa Budapesta Sucursal
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.685 | 9.601 | 14.977 | 10.681 | 2.651 | 617 | 0 | 0 | 0 | 0 |
| Current Assets | 1.048.165 | 903.603 | 963.907 | 941.002 | 927.338 | 909.576 | 889.041 | 886.589 | 1.735 | 2.141 |
| Inventories | 60.001 | 58.807 | 62.678 | 61.528 | 60.337 | 59.193 | 57.880 | 58.060 | 0 | 0 |
| Receivables | 987.694 | 843.805 | 900.681 | 878.936 | 866.475 | 849.866 | 831.161 | 828.530 | 1.735 | 2.141 |
| Cash | 469 | 991 | 548 | 538 | 527 | 517 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -118.429 | -120.431 | -124.290 | -128.578 | -129.265 | -130.683 | -129.929 | -131.974 | -167.209 | -192.047 |
| Social Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | 1.177.944 | 1.033.869 | 1.103.507 | 1.080.487 | 1.059.475 | 1.041.093 | 1.019.182 | 1.018.776 | 168.944 | 194.188 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2110 - 2110" | |||||||||
| CAEN Financial Year |
2110
|
|||||||||
Comments - Corax-Bioner Biotechnologiai Sa Budapesta Sucursala Mures